Vivos Therapeutics, Inc. Operating Cash Flow
Vivos Therapeutics, Inc. (VVOS) reported Operating Cash Flow of -$9.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.15M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.01M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.81M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.16M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$15.26M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$12.69M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$11.95M.
- Vivos Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$19.59M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$9.16M 10-Q · filed 2026-08-14 | -$12.97M derived: sum of 3 quarters · filed 2026-08-14 | -$17.13M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$6.01M 10-Q · filed 2026-05-20 | -$9.82M derived: sum of 2 quarters · filed 2026-05-20 | -$13.98M derived: sum of 3 quarters · filed 2026-05-20 | -$17.48M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$7.97M derived: sum of 2 quarters · filed 2026-04-15 | -$11.47M derived: sum of 3 quarters · filed 2026-08-14 | -$15.26M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$7.66M derived: sum of 2 quarters · filed 2026-08-14 | -$11.45M 10-Q · filed 2025-11-19 | -$14.39M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$3.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$7.29M 10-Q · filed 2026-08-14 | -$10.23M derived: sum of 3 quarters · filed 2026-08-14 | -$14.42M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$3.80M 10-Q · filed 2026-05-20 | -$6.74M derived: sum of 2 quarters · filed 2026-05-20 | -$10.92M derived: sum of 3 quarters · filed 2026-05-20 | -$13.97M derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$7.13M derived: sum of 2 quarters · filed 2026-04-15 | -$10.18M derived: sum of 3 quarters · filed 2026-04-15 | -$12.69M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | -$4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$7.24M derived: sum of 2 quarters · filed 2025-11-19 | -$9.75M 10-Q · filed 2025-11-19 | -$12.50M derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$5.56M 10-Q · filed 2025-08-19 | -$8.31M derived: sum of 3 quarters · filed 2025-08-19 | -$11.11M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$2.52M 10-Q · filed 2025-05-15 | -$5.26M derived: sum of 2 quarters · filed 2025-05-15 | -$8.06M derived: sum of 3 quarters · filed 2025-05-15 | -$10.92M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$5.55M derived: sum of 2 quarters · filed 2025-03-31 | -$8.41M derived: sum of 3 quarters · filed 2025-03-31 | -$11.95M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$5.66M derived: sum of 2 quarters · filed 2024-11-14 | -$9.20M 10-Q · filed 2024-11-14 | -$12.20M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$6.40M 10-Q · filed 2024-08-14 | -$9.40M derived: sum of 3 quarters · filed 2024-08-14 | -$15.24M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$3.54M 10-Q · filed 2024-05-14 | -$6.54M derived: sum of 2 quarters · filed 2024-07-30 | -$12.38M derived: sum of 3 quarters · filed 2024-07-30 | -$17.04M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | -$3.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | -$8.84M derived: sum of 2 quarters · filed 2024-07-30 | -$13.51M derived: sum of 3 quarters · filed 2024-07-30 | -$19.59M 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | -$5.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$10.51M derived: sum of 2 quarters · filed 2023-11-14 | -$16.59M 10-Q · filed 2023-11-14 | -$20.71M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$10.74M 10-Q · filed 2023-08-16 | -$14.87M derived: sum of 3 quarters · filed 2023-08-16 | -$18.93M derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | -$6.08M 10-Q · filed 2023-06-08 | -$10.20M derived: sum of 2 quarters · filed 2023-06-08 | -$14.26M derived: sum of 3 quarters · filed 2023-06-08 | -$17.96M derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | -$4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$8.18M derived: sum of 2 quarters · filed 2023-03-30 | -$11.87M derived: sum of 3 quarters · filed 2023-03-30 | -$15.73M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | -$7.75M derived: sum of 2 quarters · filed 2022-12-20 | -$11.61M 10-Q · filed 2022-12-20 | -$11.61M 10-Q · filed 2021-11-15 | -$15.23M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | -$3.69M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | -$7.55M 10-Q · filed 2022-12-20 | -$7.55M 10-Q · filed 2021-08-12 | -$11.17M derived: sum of 3 quarters · filed 2022-12-20 | -$11.85M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | -$3.86M 10-Q/A · filed 2022-11-25 | -$3.86M 10-Q · filed 2021-05-17 | -$7.48M derived: sum of 2 quarters · filed 2022-11-25 | -$8.15M derived: sum of 3 quarters · filed 2022-11-25 | -$9.10M derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$4.29M derived: sum of 2 quarters · filed 2022-03-31 | -$5.24M derived: sum of 3 quarters · filed 2022-03-31 | -$5.68M 10-K · filed 2022-03-31 | -$5.68M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$674.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.63M derived: sum of 2 quarters · filed 2021-11-15 | -$2.06M 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$950.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.39M 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$436.91K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$5.34M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |